Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,618.00
Bid: 1,615.00
Ask: 1,616.00
Change: 1.50 (0.09%)
Spread: 1.00 (0.062%)
Open: 1,619.50
High: 1,622.50
Low: 1,606.00
Prev. Close: 1,616.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GSK publishes provisional 2020 Dividend Dates

3 Feb 2020 15:15

RNS Number : 7940B
GlaxoSmithKline PLC
03 February 2020
 

GlaxoSmithKline plc

 

GSK publishes provisional dividend dates

 

 

 

The following amendment has been made to the 'GSK publishes 2020 Dividend Dates' announcement released on 8 January 2020 at 16:30 under RNS No 2038Z.

 

Q1 2020 Last date for DRIP elections amended to 18 June 2020.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Results announcement date

Ex-dividend date

Record date

Last date for DRIP elections

Payment date

Q1 2020

Wednesday

29 April

Thursday

14 May

Friday

15 May

Thursday

18 June

Thursday

9 July

Q2 2020

Wednesday

29 July

Thursday

13 August

Friday

14 August

Thursday

17 September

Thursday

8 October

Q3 2020

Wednesday

28 October

Thursday

12 November

Friday

13 November

Monday

21 December

Thursday

14 January 2021

Q4 2020

(Final)

Wednesday

3 February 2021

Thursday

18 February 2021

Friday

19 February 2021

Tuesday

16 March 2021

Thursday

8 April 2021

 

These dates are indicative and may be subject to change.

 

 

 

 

Victoria Whyte

Company Secretary

 

3 February 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZXLFBBLLEBBK
Date   Source Headline
13th Oct 20233:30 pmRNSDirector/PDMR Shareholding
12th Oct 20233:30 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSZantac (ranitidine) litigation
10th Oct 202311:00 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSGSK and Zhifei announce vaccine partnership
6th Oct 20237:00 amRNSGSK completes sale of shares in Haleon plc
5th Oct 20234:46 pmRNSGSK announces intention to sell shares in Haleon
2nd Oct 20233:00 pmRNSTotal Voting Rights
27th Sep 20233:00 pmRNSDirectorate Change
25th Sep 20237:00 amRNSGSK RSV vaccine for older adults approved in Japan
21st Sep 20233:30 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSApretude for PrEP receives EMA approval
18th Sep 20237:00 amRNSFDA approves Ojjaara (momelotinib)
13th Sep 20233:30 pmRNSDirector/PDMR Shareholding
11th Sep 20233:30 pmRNSDirector/PDMR Shareholding
11th Sep 20237:00 amRNSMomelotinib filing accepted in Japan
1st Sep 20233:00 pmRNSTotal Voting Rights
1st Sep 20237:00 amRNSGSK’s Nucala CRSwNP submission accepted in Japan
31st Aug 20233:16 pmRNSHolding(s) in Company
31st Aug 20233:14 pmRNSHolding(s) in Company
25th Aug 20233:30 pmRNSDirector/PDMR Shareholding
23rd Aug 20233:30 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSShingrix data demonstrate 100% efficacy in China
22nd Aug 20233:30 pmRNSDirector/PDMR Shareholding
10th Aug 20233:30 pmRNSDirector/PDMR Shareholding
9th Aug 20233:30 pmRNSDirector/PDMR Shareholding
8th Aug 20231:05 pmRNSPublication of Base Prospectus
1st Aug 20233:00 pmRNSTotal Voting Rights
31st Jul 20236:00 pmRNSFDA approves new use for Jemperli plus chemo
31st Jul 20233:30 pmRNSDirector/PDMR Shareholding
28th Jul 20233:30 pmRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNS2nd Quarter Results
24th Jul 20237:00 amRNSCabotegravir LA for PrEP receives positive CHMP
20th Jul 20233:30 pmRNSDirector/PDMR Shareholding
17th Jul 20233:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20233:00 pmRNSTotal Voting Rights
28th Jun 20233:43 pmRNSGSK completes acquisition of BELLUS Health
27th Jun 20237:00 amRNSFDA Fast Track for Gonorrhoea Vaccine Candidate
26th Jun 20237:05 amRNSShingrix approved in Japan for adults 18 and over
26th Jun 20237:00 amRNSGSK daprodustat gains positive EMA CHMP opinion
23rd Jun 20233:37 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:33 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20237:00 amRNSStatement: Zantac (ranitidine) litigation
22nd Jun 20237:00 amRNSGSK’s Arexvy recommended by ACIP
21st Jun 20237:00 amRNSSeason two data for GSK Arexvy RSV OA vaccine
16th Jun 20237:00 amRNSExtension of FDA review period for momelotinib
12th Jun 20233:30 pmRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSEU authorisation of GSK’s RSV vaccine Arexvy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.